Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Clark

Showing results (731-740 of 888) with videos related to

Pageof 89
Sort By:
Clinical Genitourinary Cancer|May 27, 2008
A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell cancerRichard T Lee, Kathleen E Beekman, Maha Hussain, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|September 15, 2018
The Application of Commercially Available Mobile Cigarette Topography Devices for E-cigarette Vaping Behavior MeasurementsVladimir B Mikheev, Stephanie S Buehler, Marielle C Brinkman, et al.
Shoulder & Elbow|December 12, 2024
Does long-term surveillance of primary linked total elbow arthroplasty identify failing implants requiring revision?Daniel Leslie James Morris, Avneet Minhas, Katherine Walstow, et al.
International Journal of Colorectal Disease|February 1, 1987
Two randomised phase II trials of intermittent intravenous versus subcutaneous alpha-2 interferon alone (trial 1) and in combination with 5-fluorouracil (trial 2) in advanced colorectal cancerP I Clark, M L Slevin, R H Reznek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1988
Monoclonal antipeptide antibodies recognize IL-3 and neutralize its bioactivity in vivoH J Ziltener, I Clark-Lewis, B Fazekas de St Groth, et al.
Cancer|June 17, 2006
A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007Francis P Worden, James Moon, Wolfram Samlowski, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1997
Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatmentJ I Clark, R K Alpaugh, M von Mehren, et al.
Nature Genetics|May 10, 2000
Mice deficient in Six5 develop cataracts: implications for myotonic dystrophyT R Klesert, D H Cho, J I Clark, et al.
The American Journal of Surgical Pathology|July 15, 2004
Metastatic juxtaglomerular cell tumor in a 52-year-old manXiuzhen Duan, Patrick Bruneval, Rasheed Hammadeh, et al.
The Journal of Biological Chemistry|July 5, 1989
Mapping of a putative surface-binding site of human coagulation factor XIIB J Clarke, H C Côté, D E Cool, et al.
Pageof 89

Showing results (731-740 of 888) with videos related to

Sort By:
Pageof 89
Clinical Genitourinary Cancer|May 27, 2008
A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell cancerRichard T Lee, Kathleen E Beekman, Maha Hussain, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|September 15, 2018
The Application of Commercially Available Mobile Cigarette Topography Devices for E-cigarette Vaping Behavior MeasurementsVladimir B Mikheev, Stephanie S Buehler, Marielle C Brinkman, et al.
Shoulder & Elbow|December 12, 2024
Does long-term surveillance of primary linked total elbow arthroplasty identify failing implants requiring revision?Daniel Leslie James Morris, Avneet Minhas, Katherine Walstow, et al.
International Journal of Colorectal Disease|February 1, 1987
Two randomised phase II trials of intermittent intravenous versus subcutaneous alpha-2 interferon alone (trial 1) and in combination with 5-fluorouracil (trial 2) in advanced colorectal cancerP I Clark, M L Slevin, R H Reznek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1988
Monoclonal antipeptide antibodies recognize IL-3 and neutralize its bioactivity in vivoH J Ziltener, I Clark-Lewis, B Fazekas de St Groth, et al.
Cancer|June 17, 2006
A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007Francis P Worden, James Moon, Wolfram Samlowski, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1997
Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatmentJ I Clark, R K Alpaugh, M von Mehren, et al.
Nature Genetics|May 10, 2000
Mice deficient in Six5 develop cataracts: implications for myotonic dystrophyT R Klesert, D H Cho, J I Clark, et al.
The American Journal of Surgical Pathology|July 15, 2004
Metastatic juxtaglomerular cell tumor in a 52-year-old manXiuzhen Duan, Patrick Bruneval, Rasheed Hammadeh, et al.
The Journal of Biological Chemistry|July 5, 1989
Mapping of a putative surface-binding site of human coagulation factor XIIB J Clarke, H C Côté, D E Cool, et al.
Pageof 89